0001179110-21-000672.txt : 20210119
0001179110-21-000672.hdr.sgml : 20210119
20210119160433
ACCESSION NUMBER: 0001179110-21-000672
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210114
FILED AS OF DATE: 20210119
DATE AS OF CHANGE: 20210119
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: TULLMAN GLEN
CENTRAL INDEX KEY: 0001213349
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37477
FILM NUMBER: 21535493
MAIL ADDRESS:
STREET 1: C/O LIVONGO HEALTH, INC.
STREET 2: 150 WEST EVELYN AVENUE, SUITE 150
CITY: MOUNTAIN VIEW
STATE: CA
ZIP: 94041
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Teladoc Health, Inc.
CENTRAL INDEX KEY: 0001477449
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011]
IRS NUMBER: 043705970
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2 MANHATTANVILLE ROAD
STREET 2: SUITE 203
CITY: PURCHASE
STATE: NY
ZIP: 10577
BUSINESS PHONE: 2036352002
MAIL ADDRESS:
STREET 1: 2 MANHATTANVILLE ROAD
STREET 2: SUITE 203
CITY: PURCHASE
STATE: NY
ZIP: 10577
FORMER COMPANY:
FORMER CONFORMED NAME: Teladoc, Inc.
DATE OF NAME CHANGE: 20091123
4
1
edgar.xml
FORM 4 -
X0306
4
2021-01-14
0
0001477449
Teladoc Health, Inc.
TDOC
0001213349
TULLMAN GLEN
C/O TELADOC HEALTH, INC.
2 MANHATTANVILLE ROAD, SUITE 203
PURCHASE
NY
10577
1
0
0
0
Common Stock
2021-01-14
4
M
0
164931
5.26
A
440724
D
Common Stock
2021-01-14
4
S
0
164931
225.12
D
275793
D
Stock Option (right to buy)
5.26
2021-01-14
4
M
0
164931
0.00
D
2021-04-30
Common Stock
164931
659725
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on December 14, 2020.
Represents the weighted average price of transactions ranging from $221.81 to $228.97. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price.
The option vested in full on October 30, 2020.
/s/ Adam C. Vandervoort, attorney-in-fact
2021-01-19